Trends in the prevalence of chronic medication use in children: 2002-2005
- PMID: 18977954
- DOI: 10.1542/peds.2008-0214
Trends in the prevalence of chronic medication use in children: 2002-2005
Abstract
Objective: Our goal was to estimate the quarterly prevalence of and evaluate trends for chronic medication use in children.
Patients and methods: A cross-sectional study of ambulatory prescription claims data from 2002 to 2005 was conducted for a nationally representative sample of >3.5 million commercially insured children who were 5 to 19 years old. Prevalence of chronic medication use was measured quarterly for antihypertensives, antihyperlipidemics, type 2 antidiabetics, antidepressants, attention-deficit disorder and attention-deficit/hyperactivity disorder medications, and asthma-controller therapy.
Results: First-quarter 2002 baseline prevalence of chronic medication use per 1000 child beneficiaries ranged from a high of 29.5 for antiasthmatics to a low of 0.27 for antihyperlipidemics. Except for asthma medication use, prevalence rates were higher for older teens aged 15 to 19 years. During the study period, the prevalence rate for type 2 antidiabetic agents doubled, driven by 166% and 135% increases in prevalence among females aged 10 to 14 and 15 to 19 years, respectively. Therapy classes with double-digit growth in prevalence of use were asthma medications (46.5%), attention-deficit disorder and attention-deficit/hyperactivity disorder medications (40.4%), and antihyperlipidemics (15%). Prevalence of use growth was more moderate for antihypertensives and antidepressants (1.8%). Rates of growth were dramatically higher among girls than boys for type 2 antidiabetics (147% vs 39%), attention-deficit disorder and attention-deficit/hyperactivity disorder medications (63% vs 33%), and antidepressants (7% vs -4%).
Conclusions: Prevalence of chronic medication use in children increased across all therapy classes evaluated. Additional study is needed into the factors influencing these trends, including growth in chronic disease risk factors, greater awareness and screening, and greater affinity toward early use of drug therapy in children.
Similar articles
-
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.Ann Pharmacother. 2008 Jan;42(1):24-31. doi: 10.1345/aph.1K143. Epub 2007 Nov 27. Ann Pharmacother. 2008. PMID: 18042808
-
Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.Arch Pediatr Adolesc Med. 2009 Apr;163(4):357-64. doi: 10.1001/archpediatrics.2009.5. Arch Pediatr Adolesc Med. 2009. PMID: 19349565
-
Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.Pediatrics. 2008 Jul;122(1):e1-6. doi: 10.1542/peds.2007-1955. Pediatrics. 2008. PMID: 18595954
-
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Ann Pharmacother. 2009. PMID: 19470858 Review.
-
Attention-deficit-hyperactivity disorder: an update.Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Pharmacotherapy. 2009. PMID: 19476419 Review.
Cited by
-
Trends in the Prevalence of Chronic Medication Use Among Children in Israel Between 2010 and 2019: Protocol for a Retrospective Cohort Study.JMIR Res Protoc. 2022 Aug 5;11(8):e36756. doi: 10.2196/36756. JMIR Res Protoc. 2022. PMID: 35775233 Free PMC article.
-
Medication-related knowledge, administration practice and adherence among caregivers of chronically ill children in Malaysia.BMC Pediatr. 2021 May 3;21(1):216. doi: 10.1186/s12887-021-02691-3. BMC Pediatr. 2021. PMID: 33941117 Free PMC article.
-
Prescribing patterns of polypharmacy in Korean pediatric patients.PLoS One. 2019 Oct 1;14(10):e0222781. doi: 10.1371/journal.pone.0222781. eCollection 2019. PLoS One. 2019. PMID: 31574095 Free PMC article.
-
Pediatric Thermoregulation: Considerations in the Face of Global Climate Change.Nutrients. 2019 Aug 26;11(9):2010. doi: 10.3390/nu11092010. Nutrients. 2019. PMID: 31454933 Free PMC article. Review.
-
Outcomes following clonidine ingestions in children: an analysis of poison control center data.Int J Emerg Med. 2019 Jul 4;12(1):14. doi: 10.1186/s12245-019-0231-1. Int J Emerg Med. 2019. PMID: 31272388 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
